Original Research
Published on 11 Nov 2025
Promiscuous class II-binding SARS-CoV-2-nuc derived vaccine-peptide induced extensive conventional, innate and unconventional T cell responses
in Vaccines and Molecular Therapeutics
- 844 views
Original Research
Published on 11 Nov 2025
in Vaccines and Molecular Therapeutics
Case Report
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 11 Nov 2025
in Aging and Public Health
Perspective
Published on 11 Nov 2025
in Genetics and Epidemiology
Case Report
Published on 11 Nov 2025
in Pediatric Urology
Systematic Review
Published on 11 Nov 2025
in Cardiovascular Nursing
Original Research
Published on 11 Nov 2025
in Case Management
Original Research
Published on 11 Nov 2025
in Headache and Neurogenic Pain
Original Research
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 11 Nov 2025
in Food Chemistry
Mini Review
Published on 11 Nov 2025
in Behavioral Endocrinology
Original Research
Published on 11 Nov 2025
in Intensive Care Cardiovascular Medicine
Original Research
Published on 11 Nov 2025
in Software
Opinion
Published on 11 Nov 2025
in Blue Food Provisions
Policy and Practice Reviews
Published on 11 Nov 2025
in Neglected Tropical Diseases
Original Research
Published on 11 Nov 2025
in Cellular Biochemistry